ralinepag
ralinepag: sourced relationships with 1 company · 3 clinical trials tracked.
ralinepag evidence translation
What we can confirm
3 tracked trials
What it means
What to watch
Prepared research question
How could ralinepag → ARNA affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence7 indications · 1 study sponsors
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| ARENA PHARMACEUTICALS INC (ARNA) | Phase 3 |
Clinical Trial Registry Records (3)
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
Primary endpoint: Change From Baseline in Peak VO2 Assessed by CPET
A Phase 3 Open-label Extension (OLE) Study to Evaluate the Long-term Safety and Efficacy of Ralinepag in Subjects With World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension (PAH)
Primary endpoint: Number of subjects with treatment-emergent adverse events [Safety and Tolerability]
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Primary endpoint: Time from randomization to the first adjudicated protocol-defined clinical worsening event
Frequently asked questions
Which companies have sourced relationships with ralinepag?
ralinepag has dated SEC/FDA relationship records for ARENA PHARMACEUTICALS INC.
How many clinical trials involve ralinepag?
BioSniper tracks 3 clinical trials involving ralinepag.